<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="34118">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02662439</url>
  </required_header>
  <id_info>
    <org_study_id>HF-BCM-15-1</org_study_id>
    <nct_id>NCT02662439</nct_id>
  </id_info>
  <brief_title>Bioimpedance Analysis in Chronic Heart Failure</brief_title>
  <official_title>Role of the Bioimpedance Analysis in Guiding the Diuretic Therapy in Chronic Heart Failure - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Studinger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University</source>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether the objective measurement of fluid overload
      by bioimpedance analysis (Body Composition Monitor-BCM) in patient with acute decompensated
      heart failure would improve the diuretic therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Re-hospitalization rate</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>Measured by validated questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Renal function decline</measure>
    <time_frame>3 months</time_frame>
    <description>Measured by estimated glomerular filtration rate (ml/min/1.73m2)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>BCM group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients are measured by Body Composition Monitor (BCM) and both the patient and the physician know the results and adjust the diuretic therapy accordingly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The patients are measured by Body Composition Monitor (BCM) but neither the patient nor the physician know the results, the physician adjusts the diuretic therapy as usual, according to the protocols.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Body Composition Monitor (BCM)</intervention_name>
    <description>In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.</description>
    <arm_group_label>BCM group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with known or newly discovered chronic heart failure admitted to hospital
             because of the clinical signs of acut cardiac decompensation

        Exclusion Criteria:

          -  High level of fatigue (the patient cannot stand on a scale)

          -  Amputated upper and/or lower limb(s)

          -  The BCM analysis is not possible technically (e.g. open wounds on the limbs)

          -  Severe obesity (&gt;130 kg)

          -  Patients on chronic hemodialysis or peritoneal dialysis

          -  Severe fluid volume in the transcellular space

          -  Patients with a unipolar pacemaker whose sensitivity threshold is very low

          -  Pregnancy, lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Studinger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Department of Medicine, Semmelweis University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nora Ledo, MD</last_name>
    <phone>+36206663566</phone>
    <email>ledo.nora@med.semmelweis-univ.hu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter Studinger, MD, PhD</last_name>
    <phone>+36208258670</phone>
    <email>studinger.peter@med.semmelweis-univ.hu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Department of Medicine, Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Studinger, MD, PhD</last_name>
      <phone>+36208258670</phone>
      <email>studinger.peter@med.semmelweis-univ.hu</email>
    </contact>
    <contact_backup>
      <last_name>Nora Ledo, MD</last_name>
      <phone>+36206663566</phone>
      <email>ledo.nora@med.semmelweis-univ.hu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 6, 2016</lastchanged_date>
  <firstreceived_date>January 14, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Peter Studinger</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Bioimpedance analysis</keyword>
  <keyword>Fluid overload</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diuretics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
